Molecular cancer biomarkers are any measurable molecular indicator of risk of cancer,
occurrence of cancer, or patient outcome. They may include germline or somatic genetic …

Abstract Internet of Medical Things (IoMT) supports traditional healthcare systems by
providing enhanced scalability, efficiency, reliability, and accuracy of healthcare services. It …

In the past decade, single-cell technologies have revealed the heterogeneity of the tumor-
immune microenvironment at the genomic, transcriptomic, and proteomic levels and have …

Metabolomics is a discipline aiming to characterize the presence of metabolites in biological
matrices under specific conditions. In recent years, metabolomics has increasingly been …

The discovery and identification of biomarkers promote the rational and fast development of
medical diagnosis and therapeutics. Clinically, the application of ideal biomarkers still is …

Metabolomics is a young field of knowledge that arises linked to other omics such as
genomics, transcriptomics, and proteomics. This discipline seeks to understand the …

The lacrimal film has attracted increasing interest in the last decades as a potential source of
biomarkers of physiopathological states, due to its accessibility, moderate complexity, and …

Biomarkers are detectable molecules that can reflect specific physiological states of cells,
organs, and organisms and therefore be regarded as indicators for specific diseases. And …

Glioblastoma is the most common malignant brain tumor in adults. The current management
relies on surgical resection and adjuvant radiotherapy and chemotherapy. Despite …

The diagnosis of glioma is mainly based on imaging methods that do not distinguish
between stage and subtype prior to histopathological analysis. Patients with gliomas are …